Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07002840

Effect of Cross-legged Sitting Among Patients With Unilateral Hip Developmental Dysplasia

One of the most common infant developmental diseases is Hip dysplasia which is mostly seen among female' babies and leads to hip instability due to partial or full hip dislocation [1]. Physical therapy's role plays a significant role in treating hip dysplasia by creating new walking habits as an adaptation way and compensation for the deformity [3]. Focusing on the muscles that produce hip abduction force is a basic item of the hip dysplasia rehabilitation program [4]. Cross-legged sitting position can be considered as a common and easy position that might enhance the range of motion of the lower limb joints [5].

While unilateral hip developmental dysplasia has been widely distributed among newborns, especially in the last few years, the role of engaging the cross-legged sitting technique as a part of physical therapy and rehabilitation programs on improving the temporospatial parameters, muscular electrical activity and foot pressure distributing is still not clear. Therefore, this study aimed to analyze the effects of engaging the cross-legged sitting technique as a part of physical therapy and rehabilitation program among patients with UHDD by comparing the group who participated in rehabilitation program with CLS to the other without.

To understand the importance of including Cross-legged sitting technique in physical therapy and rehabilitation program of Unilateral Hip Developmental Dysplasia (UHDD) to enhance the spatial and temporal measures, achieving a healthy distribution of foot pressure, increasing the electrical activity of lower limb muscles and improving the overall gait pattern.

No risks at all. All instruments and techniques in this study are safe and used regularly without any hazards.

The data will be stored and archived on a password-protected computer for safety and security purposes. After accomplishing the research and getting the outcomes, the results of the research may be published as an academic article in a peer-reviewed journal. In another word, no personal data will be published at all.

Taking part in the study and withdrawing at any time is completely voluntary with no need to give any reason.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age group from 9 months to 10 years old
  • all participants suffer from Unilateral Hip Developmental Dysplasia (UHDD)
  • participants should be healthy in general

Exclusion criteria

Any participant with a history of neurological disorders, lower extremities previous surgical intervention, lower limb deformities, flat feet or high body mass index will be excluded from this study

Treatment and study plan

Cross- legged sitting position

Other

CLS in which the legs were crossed with hip and knee joints flexed

Physical Therapy Rehabilitation Program

Other

Strengthening Exercises Stretching Exercises Range of Motion Exercises

Primary outcomes

  1. Gait Temporospatial Parameters

    Time frame: 3 months

    Cadence will be measured by Gait Rite

  2. Muscle Electrical Activity

    Time frame: 3 months

    Muscle Electrical Activity will be measured by Electromygraphy

Secondary outcomes

  1. Foot Pressure

    Time frame: 3 months

    Average pressure will be measured using the foot pressure system

Study contacts

Contact information is provided by the study sponsor or research team.

Hadeel Alsirhani, PhD

CONTACT

[email protected]

+966556256464

Sponsors and collaborators

Lead sponsor

Jouf University

Other

Registry information

Official study title

Effect of Engaging the Cross-legged Sitting in Rehabilitation Among Patients With Unilateral Hip Developmental Dysplasia According to Gait Parameters, Foot Pressure and Muscular Electrical Activity.

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Jun 4, 2025
Registry last updated
Jun 4, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.